EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

A Multisite Retrospective Review of Direct Oral Anticoagulants Compared to Warfarin in Adult Fontan Patients

Amir Kazerouninia iD, Justin Georgekutty, Payton Kendsersky, Ryan D Byrne, Brendan Seto, Patricia Y Chu, Yunfei Wang, Fred H Rodriguez, Clayton Smith, Anita Saraf, Michael S Lloyd, Benjamin P Frischhertz und 4 weitere

Cardiovascular Drugs and Therapy · 2023-06 · 37 (3) · 519-527

DOI: 10.1007/s10557-021-07298-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 13.01.2022. Verfasst von Amir Kazerouninia und 15 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Internal Medicine and Pediatrics, Baylor College of Medicine, Houston, TX, USA. akazerouninia@gmail.com. Hauptthemen laut MEDLINE: Atrial Fibrillation, Stroke. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Direct oral anticoagulants (DOACs) are not recommended in adult Fontan patients (Level of Evidence C). We hypothesized that DOACs are comparable to warfarin and do not increase thrombotic and embolic complications (TEs) or clinically significant bleeds. METHODS: We reviewed the medical records of adult Fontan patients on DOACs or warfarin at three major medical centers. We identified 130 patients: 48 on DOACs and 107 on warfarin. In total, they were treated for 810 months on DOACs and 5637 months on warfarin. RESULTS: The incidence of TEs in patients on DOACs compared to those on warfarin was not increased in a statistically significant way (hazard ratio [HR] 1.7 and p value 0.431). Similarly, the incidence of nonmajor and major bleeds in patients on DOACs compared to those on warfarin was also not increased in a statistically significant way (HR for nonmajor bleeds in DOAC patients was 2.8 with a p value of 0.167 and the HR for major bleeds was 2.0 with a p value 0.267). In multivariate analysis, congestive heart failure (CHF) was a risk factor for TEs across both groups (odds ratio [OR] = 4.8, 95% confidence interval [CI] = 1.3-17.6) and bleed history was a risk factor for clinically significant bleeds (OR = 6.8, 95% CI = 2.7-17.2). CONCLUSION: In this small, retrospective multicenter study, the use of DOACs did not increase the risk of TEs or clinically significant bleeds compared to warfarin in a statistically significant way.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationStrokeHumansAdultWarfarinAnticoagulantsRetrospective StudiesHemorrhageAdministration, OralMulticenter Studies as Topic

Stichwörter der Autor:innen

ACHDAnticoagulationDOACFontanThrombus

Substanzen

WarfarinAnticoagulants

Autor:innen und Institutionen

  • Departments of Internal Medicine and Pediatrics, Baylor College of Medicine, Houston, TX, USA. akazerouninia@gmail.com.
  • Division of Pediatric Cardiology, Cohen Children's Medical Center/Northwell Health, New Hyde Park, NY, USA.
  • Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Departments of Internal Medicine and Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
  • University of Hawaii, John A. Burns School of Medicine, Honolulu, HI, USA.
  • Division of Pediatric Cardiology, Texas Children's Hospital/Baylor College of Medicine, Houston, TX, USA.

ORCID-Profile: Amir Kazerouninia

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Kazerouninia, A., Georgekutty, J., Kendsersky, P., Byrne, R. D., Seto, B., Chu, P. Y., Wang, Y., Rodriguez, F. H., Smith, C., Saraf, A., Lloyd, M. S., Frischhertz, B. P., Parekh, D. R., Ermis, P. R., Franklin, W. J., & Lam, W. W. (2023). A Multisite Retrospective Review of Direct Oral Anticoagulants Compared to Warfarin in Adult Fontan Patients. Cardiovascular Drugs and Therapy, 37(3), 519-527. https://doi.org/10.1007/s10557-021-07298-5

Vancouver

Kazerouninia A, Georgekutty J, Kendsersky P, Byrne RD, Seto B, Chu PY, et al. A Multisite Retrospective Review of Direct Oral Anticoagulants Compared to Warfarin in Adult Fontan Patients. Cardiovascular Drugs and Therapy. 2023;37(3):519-527. doi:10.1007/s10557-021-07298-5

BibTeX
@article{Kazerouninia2023,
  author = {Kazerouninia, Amir and Georgekutty, Justin and Kendsersky, Payton and Byrne, Ryan D and Seto, Brendan and Chu, Patricia Y and Wang, Yunfei and Rodriguez, Fred H and Smith, Clayton and Saraf, Anita and Lloyd, Michael S and Frischhertz, Benjamin P and Parekh, Dhaval R and Ermis, Peter R and Franklin, Wayne J and Lam, Wilson W},
  title = {A Multisite Retrospective Review of Direct Oral Anticoagulants Compared to Warfarin in Adult Fontan Patients},
  journal = {Cardiovascular Drugs and Therapy},
  year = {2023},
  volume = {37},
  number = {3},
  pages = {519--527},
  doi = {10.1007/s10557-021-07298-5}
}
Kostenlos starten →